Feeling Cold While Taking Wegovy: What's Really Going On

What the trial data and official guidance actually say about cold sensitivity

The published trial programme for semaglutide 2.4mg (including the STEP 1 study in the New England Journal of Medicine, which followed 1,961 adults over 68 weeks) recorded side effects rigorously. Cold intolerance does not appear as a frequently reported adverse event in those results. The Wegovy SmPC lists the predominant side effects as gastrointestinal: nausea, diarrhoea, vomiting, constipation and indigestion are common, especially around dose increases, and you can read more about feeling sick on Wegovy if nausea is something you're also navigating. Feeling cold is not in that primary list.

That doesn't mean the experience isn't real for the people who have it. It means the mechanism is indirect. Body fat is one of the body's most effective insulators. As fat mass decreases (sometimes substantially on a medicine that produced roughly 15% average weight reduction in STEP 1) the thermal buffer that kept you warm at your previous weight is simply smaller. If you want a thorough look at whether being cold is a side effect of Wegovy, including how to distinguish a drug effect from the consequences of fat loss, that page works through the evidence in detail. The NHS patient information on semaglutide is honest about the side-effect profile and is a sensible first reference when you want to cross-check your own experience.

One practical note: the timing of this sensation tends to follow the rate of weight loss rather than the dose level, which means it can emerge a few months in rather than at the very start, sometimes around the point people are consolidating on a maintenance dose.

Other reasons Wegovy patients report feeling cold, and how to tell them apart

A few other mechanisms are worth knowing about. First, fatigue. Tiredness is a recognised early side effect of semaglutide treatment, and if you want a fuller picture of why feeling tired on Wegovy is something many patients notice, that experience can make temperature regulation feel worse subjectively, when your energy is low, cold feels colder. This tends to settle as the body adjusts, usually within the first few weeks of a new dose.

Second, caloric restriction. Wegovy works in part by reducing appetite significantly. If food intake drops a long way, the body produces less metabolic heat. This is a common experience with any effective weight-loss approach and is not unique to GLP-1 medicines. Keeping protein intake adequate (something to discuss with your prescriber or a dietitian) supports lean muscle, which is metabolically active and contributes to warmth.

Third, and less commonly, some people develop iron-deficiency anaemia during periods of significant weight loss, particularly if their diet changes substantially. Anaemia is a well-known cause of feeling cold. If you're also feeling breathless, unusually pale, or your heart seems to race on minimal exertion, mention it at your next clinical review. Similarly, thyroid function changes can cause cold intolerance; if you have a thyroid history, your GP can check levels with a simple blood test.

Separating these possibilities matters because the responses are different: if it's fat loss, layering up more is the main answer; if it's anaemia or thyroid, investigation and treatment change the picture. The full side-effect profile of Wegovy covers the broader landscape if you want to see how cold sensitivity fits alongside other commonly reported experiences.

When feeling cold on Wegovy should prompt medical advice

Most cold sensitivity linked to weight loss is benign and self-limiting. A few situations warrant more urgent attention. Get medical help promptly if you experience severe, persistent abdominal pain that extends towards your back (with or without vomiting) as this could indicate acute pancreatitis, which the MHRA flagged in a January 2026 Drug Safety Update as a known, infrequent but potentially serious GLP-1 side effect. That's unrelated to cold specifically, but worth knowing as you read about any new symptom.

For cold sensitivity specifically, our page on Wegovy side effects and cold goes into more detail, but as a general guide you should seek clinical advice if: it comes on suddenly rather than gradually; it's accompanied by unexplained fatigue that isn't improving; you notice swelling in your neck, unexplained weight gain, or constipation beyond what's typical for GLP-1 treatment; or the cold sensation is affecting your quality of life significantly. Your GP can run blood tests to rule out thyroid dysfunction and anaemia quickly.

Reporting unexpected or persistent side effects through the MHRA Yellow Card scheme is genuinely useful, Wegovy carries a Black Triangle (▼) status in the UK, meaning the MHRA is actively collecting post-market safety data. Your report contributes to that picture. You can also contact our team seven days a week if you're uncertain whether something needs attention sooner.

What to do practically if you're cold on Wegovy

For the majority of people, the answer is reassuringly mundane. The body adjusts to a lower fat mass over time, and many people find the sensation of feeling cold gradually settles, or they adapt to it without it mattering much. Practical steps that help: prioritise protein and iron-rich foods in your reduced-calorie eating pattern; keep up strength-based activity, which supports muscle mass and metabolic rate; and layer clothing appropriately, especially in winter. If you're placing an order on a cold January Monday and wondering whether the pen needs to go straight in the fridge, it does, but the brief delivery window is handled within the tracked DPD transit guidelines.

If you're considering Wegovy and want to understand how suitability is assessed, including whether your health history affects the picture, our clinical team reviews every consultation personally. You can read more about Wegovy as a treatment or explore all available options on our treatment page. Our prescribers discuss side effects and individual suitability as part of the consultation, it's not a box-ticking exercise. The clinical oversight behind the service reflects that approach.